Human Milk Oligosaccharides (HMO) Market Size - By Concentration (Neutral HMO, Acidic HMO), By Application (Infant Formula, Dietary Supplements, Food and Beverage) & Global Forecast, 2023 – 2032

Human Milk Oligosaccharides Market Size

Human Milk Oligosaccharides Market size was valued at USD 200 million in 2022 and is estimated to grow at over 22.5% CAGR from 2023 to 2032. Human milk oligosaccharides are present in breast milk and play essential roles in infant gut health, immune system development, and protection against pathogens. Infant formula manufacturers are incorporating HMOs in their products to mimic the benefits of human breast milk.
 

HMOs act as prebiotics, promoting the growth of beneficial gut bacteria and supporting a healthy gut microbiome. Consumers are increasingly aware of the importance of gut health and seek products with prebiotic properties. HMOs have been associated with immune system support and reduced risk of infections in infants. The demand for immune-enhancing ingredients has led to interest in HMOs as functional food ingredients.

The production of HMOs, particularly those obtained through microbial fermentation or plant-based sources, can be expensive. The cost of production is a significant challenge that can limit the widespread adoption of HMOs in various applications, including infant formula and functional foods. The use of HMOs in food and dietary supplements is subject to regulatory approvals in different countries. Human milk-derived HMOs are in high demand, but their availability is limited to the production of human breast milk.
 

COVID-19 Impact

The pandemic led to changes in consumer behaviour, with increased focus on health and wellness. This shift may have driven demand for products with added health benefits, including HMOs, which are known for their potential gut health and immune system benefits. The demand for infant formula, which is one of the key applications of HMOs, experienced fluctuations during the pandemic. Thus, the reduced number of COVID-19 cases and implementation of subsequent strategies by government and non-government organizations is set to drive the market growth.
 

Human Milk Oligosaccharides Market Trends

There is a growing focus on gut health and its impact on overall well-being. HMOs are recognized for their prebiotic properties, promoting the growth of beneficial gut bacteria, and supporting a healthy gut microbiome. As consumers become more health-conscious, products containing HMOs as gut health enhancers are gaining popularity. HMOs play a vital role in human breast milk and contribute to infant gut health and immune system development.
 

Consequently, HMOs are being incorporated into infant formulas and baby foods to replicate some of the benefits of breast milk for formula-fed babies. The demand for HMOs in infant nutrition is increasing as parents seek functional ingredients for their babies' health.
 

Human Milk Oligosaccharides Market Analysis

The human milk oligosaccharides market from neutral HMO segment held over USD 122 million revenue in 2022. Neutral HMOs, like other HMOs, have prebiotic effects, supporting the growth of beneficial gut bacteria and promoting a healthy gut microbiome. A healthy gut microbiome is associated with improved gut health and enhanced immune system function. Neutral HMOs are known for their anti-adhesive properties, which means they can prevent pathogens from adhering to the intestinal lining.
 

The infant formula segment accounted for 40% of the human milk oligosaccharides market share in 2022. HMOs are naturally present in human breast milk and play a crucial role in infant gut health, immune system development, and protection against pathogens. The desire to provide similar health benefits to formula-fed infants drove the demand for HMOs in infant formula and baby foods. Research on HMOs has revealed their potential therapeutic applications, such as in reducing the risk of infections in preterm infants and supporting gut health in individuals with gastrointestinal disorders.
 

U.S. human milk oligosaccharides market size dominated around USD 62.72 million in 2022. North American consumers are increasingly focused on health and wellness, seeking products that offer functional benefits. HMOs are known for their potential gut health and immune system benefits, making them attractive to health-conscious consumers in the region.
 

Human Milk Oligosaccharides Market Share

Some of the major companies operating in the human milk oligosaccharides market are:

• DuPont Nutrition & Biosciences
•  Jennewein Biotechnologie GmbH
•  Glycom A/S
•  Inbiose NV
•  BASF SE
•  Nestlé S.A
•  Abbott Laboratories
•  Glycosyn LLC
•  ZuChem Inc
• Tereos Starch & Sweeteners
•  Jenica Research Corporation
•  Novalac
•  GlycoUniverse GmbH
•  Biostime International Holdings Limited
•  Clasado Biosciences.
   

These companies focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these companies are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.
 

Human Milk Oligosaccharides Industry News:

• In August 2021, Nestle launched the new NAN SUPREME PRO 3 formula products with five human milk oligosaccharides (2’-FL, DFL, LNT, 3’-SL, and 6’-SL), which it claims enhance children’s immunity systems.
   

This human milk oligosaccharides market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million & Units from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

Market, By Concentration

• Neutral HMO
• Acidic HMO

Market, By Application

• Infant Formula
• Dietary Supplements
• Food and Beverage
• Others

The above information has been provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Malaysia 
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt